Breaking News, Promotions & Moves

Novotech Appoints Dr. Anand Tharmaratnam as CEO

Tharmaratnam brings nearly three decades of experience in the global CRO industry and has served as Novotech Chairman since 2021.

Author Image

By: Charlie Sternberg

Associate Editor

Dr. Anand Tharmaratnam.

Novotech, a full-service biotech clinical research organization (CRO), has appointed Dr. Anand Tharmaratnam as its new Chief Executive Officer (CEO). Tharmaratnam brings nearly three decades of experience in the global CRO industry and has served as Novotech Chairman since 2021. He commenced as Chairman and CEO on January 1, 2026. Reflecting Novotech’s increasingly international profile, Tharmaratnam will be based at the company’s new global headquarters in Singapore. In early September 20...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics